(Q45770920)
Statements
Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity (English)
D R Skillman
C F Decker
K F Wagner
R L Mapou
M J Liao
D Testa